The majority of studies indicated that the MCHR1 antagonists are effective in different models of obesity in a variety of different rodent strains, due to inhibition of food intake and/or energy expenditure (40, 41). This evidence concerns the gene MCHR1 and obesity due to melanocortin 4 receptor deficiency.